Heart Failure Prognosis

Recovery of Worsening Renal Func on A er Acute Heart Failure

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESC-HF 2026 Worsening renal function (WRF) frequently occurs during hospitalization for acute decompensated heart failure (ADHF), although its prognostic significance remains controversial because transient creatinine increases may reflect effective decongestion or initiation of guideline-directed medical therapy rather than irreversible renal injury. This study evaluated the rate of WRF recovery after […]

Recovery of Worsening Renal Func on A er Acute Heart Failure Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , , ,

Long Term Outcomes with Sacubitril Valsartan in HFrEF: Insights From a Real World Cohort

by Prateek Chopra | June 1, 2026 | Cardiology Conferences | ESC-HF 2026 Sacubitril–valsartan (SV) has shown prognostic benefits in patients with heart failure with reduced ejection fraction (HFrEF), although its long-term real-world impact remains unclear. This study assessed long-term outcomes associated with SV use in a real-world HFrEF cohort. The findings were presented at Heart Failure 2026, organized by the

Long Term Outcomes with Sacubitril Valsartan in HFrEF: Insights From a Real World Cohort Read Post »

Leave a Comment / ESC-HF Day 4 / / / , , , ,

The Prognostic Role of Regular NT-proBNP Measurement A er a Rapid-Up Titration Programme of Guideline-Directed Medical Therapy in Heart Failure: Essential or Superfluous?

by Prateek Chopra | May 25, 2026 | Cardiology Conferences | ESC-HF 2026 N-terminal pro-B-type natriuretic peptide (NT-proBNP) is an important prognostic biomarker in heart failure (HF). The 2023 ESC HF Guidelines recommend rapid up-titration (RT) of guideline-directed medical therapy (GDMT) following an index HF hospitalization; however, the prognostic significance of NT-proBNP changes after a rapid titration programme (RTP) remains uncertain.

The Prognostic Role of Regular NT-proBNP Measurement A er a Rapid-Up Titration Programme of Guideline-Directed Medical Therapy in Heart Failure: Essential or Superfluous? Read Post »

Leave a Comment / ESC-HF Day 2 / / / , , , ,

Predictors of Heart Failure with Improved Ejection on Frac on: A Real-World Analysis

by Prateek Chopra | May 22, 2026 | Cardiology Conferences | ESC-HF 2026 Heart failure with improved ejection fraction (HFimpEF) is increasingly recognized as a clinically meaningful phenotype in patients with heart failure with reduced ejection fraction (HFrEF). However, the factors associated with improvement in left ventricular ejection fraction (LVEF) remain incompletely understood. This study aimed to identify predictors associated with

Predictors of Heart Failure with Improved Ejection on Frac on: A Real-World Analysis Read Post »

Leave a Comment / ESC-HF Day 2 / / / , , , ,

Left Ventricular Ejection on Fraction, Ventricular Remodelling and Outcomes After Sacubitril – Valsartan in a Real-Life Cohort

by Prateek Chopra | May 17, 2026 | Cardiology Conferences | ESC-HF 2026 Sacubitril–valsartan (SV) has demonstrated prognostic benefits in patients with heart failure with reduced ejection fraction (HFrEF), although its long-term impact in real-world clinical practice remains unclear. This study assessed long-term outcomes associated with SV use in a real-world HFrEF cohort. The findings were presented at Heart Failure 2026,

Left Ventricular Ejection on Fraction, Ventricular Remodelling and Outcomes After Sacubitril – Valsartan in a Real-Life Cohort Read Post »

Leave a Comment / ESC-HF Day 1 / / / , , , ,

The Prognostic Value of NT-proBNP Variability Measured During Rou ne Follow-Up in Outpatients with Heart Failure with Reduced Ejection Fraction

by Prateek Chopra | May 19, 2026 | Cardiology Conferences | ESC-HF 2026 N-terminal pro–B-type natriuretic peptide (NT-proBNP) is an established biomarker for risk stratification in Heart Failure with reduced ejection fraction (HFrEF). However, the prognostic significance of serial variability in NT-proBNP levels during routine follow-up in clinically stable patients remains unclear. This study aimed to determine whether fluctuations in NT-proBNP

The Prognostic Value of NT-proBNP Variability Measured During Rou ne Follow-Up in Outpatients with Heart Failure with Reduced Ejection Fraction Read Post »

Leave a Comment / ESC-HF Day 1 / / / , , , ,
Scroll to Top